Two more treatments for men with advanced prostate cancer could soon be available, according to updated findings from two phase III clinical trials presented in San Francisco last week at the 2012 Genitourinary Cancers Symposium. Read more > >
by Dr. Nils Daulaire
To mark World Cancer Day on February 4, the director of the Office of Global Affairs at the U.S. Department of Health and Human Services talks about why the United States should be involved in initiatives to improve global health.
- Drug to Treat Basal Cell Skin Cancer Approved after Priority Review
- Drug Approved for Advanced Kidney Cancer
- Imatinib Granted Expanded Use in Patients with Rare Gastrointestinal Tumors
- NCI Wins Two Awards for Tech Transfer Excellence
- Kevin White to Speak on Genomic Networks in Development and Cancer
- NCI to Hold Symposium on Translational Genomics
- New Issue of CCR Connections Published
- Smartphone App to Help Teens Quit Smoking Now Available
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at email@example.com.